Vanguard Group Inc. Acquires 41,683 Shares of Integral Ad Science Holding Corp. $IAS

Key Points

• Vanguard Group Inc. increased its stake in Integral Ad Science Holding Corp. by 0.5% in the first quarter, owning approximately 9.09 million shares valued at $73.27 million as of its latest SEC filing.
• Institutional investors now own 95.78% of Integral Ad Science, with various hedge funds acquiring new stakes totaling significant investments in recent quarters.
• Integral Ad Science reported a net margin of 9.79% and earnings per share of $0.07 for the last quarter, exceeding analyst expectations and setting guidance for future earnings.

Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 0.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,090,229 shares of the company's stock after buying an additional 41,683 shares during the quarter. Vanguard Group Inc. owned about 5.55% of Integral Ad Science worth $73,267,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Alyeska Investment Group L.P. acquired a new stake in shares of Integral Ad Science during the fourth quarter worth approximately $41,543,000. Dimensional Fund Advisors LP boosted its stake in Integral Ad Science by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after acquiring an additional 580,323 shares during the last quarter. Clearline Capital LP bought a new position in Integral Ad Science in the fourth quarter valued at approximately $3,949,000. Invenomic Capital Management LP boosted its position in shares of Integral Ad Science by 52.9% during the fourth quarter. Invenomic Capital Management LP now owns 895,061 shares of the company's stock worth $9,344,000 after purchasing an additional 309,752 shares in the last quarter. Finally, Ararat Capital Management LP boosted its position in shares of Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock worth $23,823,000 after purchasing an additional 269,346 shares in the last quarter. 95.78% of the stock is currently owned by institutional investors.

Integral Ad Science Price Performance

IAS stock traded down $0.15 during trading on Friday, reaching $8.99. 765,289 shares of the company were exchanged, compared to its average volume of 882,123. Integral Ad Science Holding Corp. has a twelve month low of $6.26 and a twelve month high of $13.62. The company has a 50-day moving average of $8.46 and a two-hundred day moving average of $8.38. The company has a market capitalization of $1.49 billion, a price-to-earnings ratio of 26.44, a P/E/G ratio of 1.33 and a beta of 1.57.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Integral Ad Science had a net margin of 9.79% and a return on equity of 5.00%. The firm had revenue of $149.20 million during the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, analysts forecast that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on IAS shares. Wall Street Zen upgraded shares of Integral Ad Science from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Stifel Nicolaus lifted their price target on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. Raymond James Financial decreased their price objective on shares of Integral Ad Science from $13.00 to $11.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Finally, Barclays lifted their price objective on shares of Integral Ad Science from $9.00 to $10.00 and gave the company an "equal weight" rating in a research report on Friday, August 8th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Integral Ad Science presently has an average rating of "Moderate Buy" and an average target price of $13.55.

Insiders Place Their Bets

In other Integral Ad Science news, CEO Lisa Utzschneider sold 14,904 shares of the company's stock in a transaction on Tuesday, July 8th. The shares were sold at an average price of $8.31, for a total transaction of $123,852.24. Following the transaction, the chief executive officer owned 379,316 shares in the company, valued at approximately $3,152,115.96. This represents a 3.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders have sold a total of 35,073 shares of company stock worth $289,641 in the last 90 days. Corporate insiders own 2.00% of the company's stock.

Integral Ad Science Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.